South Wales, June 27 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Cognat-IVE" on June 15. The details about the trademark application no. UK00004219142 published in the journal no. 2025/026 (June 27).
Cognat-IVE LTD filed the trademark application for the below mentioned good(s)/service(s).
Class 9 : Software for capturing, processing, and modeling cognitive and motor intention using electroencephalographic (EEG) and neurophysiological signals; artificial intelligence and neural decoding systems for interpreting neurological data and enabling autonomous system control; neurotechnology software for high-dimensional vector trajectory analysis and semantic memory encoding; software tools for assistive neuroprosthetics and adaptive interfaces; downloadable and cloud-based cognitive computing platforms for brain-computer interface (BCI) research and autonomous general-purpose agent integration.
Class 10 : Wearable neurotechnology devices for cognitive and motor intention detection; EEG-based prosthetic control interfaces; brain-computer interface medical systems; neural monitoring devices for clinical and research applications.
Class 41 : Educational services relating to brain-computer interfaces, neurotechnology, cognitive signal processing, and the development of adaptive AI systems; workshops, courses, and instructional materials on EEG interpretation and human-computer interaction.
Class 42 : Design and development of cognitive computing and brain-computer interface systems; research and development of artificial intelligence for neurological signal interpretation, prosthetic control, and assistive technology integration; software-as-a-service (SaaS) platforms for intent recognition, adaptive system navigation, and neurofeedback; scientific services in the fields of neural signal processing, semantic memory reconstruction, and human-machine intent modeling; integration of cognitive state engines with autonomous and general-purpose intelligent agents.
Class 44 : Medical and neurological signal analysis services for cognitive state interpretation and motor intention detection; assistive technology services for individuals with cerebral palsy, paralysis, amputations, or neuromotor disorders; application of brain-computer interface systems for clinical use, prosthetic control, and autonomous interface navigation; neurofeedback services for cognitive and physical rehabilitation; non-invasive brain monitoring and therapeutic biofeedback systems using adaptive AI models.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004219142
Disclaimer: Curated by HT Syndication.
